News – Page 927 – Endpoints News

FDA rejects Kala's dry eye drug; Troubled Insys finds a buyer (of some assets) in Hikma

6 years ago

Top Scripps scientist and biotech co-founder makes an abrupt — and unexplained — exit

6 years ago

Apple devices, in tandem with digital apps, could detect early signs of Alzheimer's, dementia: study

6 years ago

Melinta chief John Johnson jumps ship — with the chairman — from another troubled antibiotics play

6 years ago

Fabry disease: FDA drafts drug development guidance

6 years ago

Amy Burroughs to lead Cleave Therapeutics; Cynthia Collins clinches Editas CEO job amid historic CRISPR move

6 years ago

AstraZeneca's flagship Tagrisso helps lung cancer patients live longer in pivotal study

6 years ago

Mystery solved? Nektar chief says 'softening' in patient responses to bempeg was a CMC issue — spurring a rout

6 years ago

The FDA decides to hold an expert panel review of Vascepa after all — and Amarin shares tank on unexpected delay

6 years ago

Sarepta shares slammed on report gene therapy Duchenne MD patient was hospitalized, but the company says it is ...

6 years ago

Boris Johnson pledges £250M to spur AI adoption in NHS; SQZ scoops CFO Teri Loxam from Merck

6 years ago

New exec team, new money and a big syndicate — ORIC heads to PhII

6 years ago

Alexandria seals $143M deal in Seattle's 'heart of the heart,' grabbing coveted land to build its biotech cluster

6 years ago

More research is needed to justify use of 'medicinal' cannabis: UK agencies

6 years ago

The FDA’s very public slap of Novartis’ red face is a warning to the entire industry — don’t downplay it

6 years ago

FDA AdCom backs Gilead's move to expand Descovy label — but stops short of endorsing broad PrEP use

6 years ago

Bayer’s $240M upfront for BlueRock acquisition puts them in the high rollers club for preclinical biotech buyouts

6 years ago

CMS will now cover pricey CAR-T therapies for Medicare patients

6 years ago

Bayer is going all in on next-gen stem cell biotech BlueRock, buying out Versant and founders for $600M

6 years ago

Gilead's newly departed R&D chief re-emerges as CEO of a rival hep B biotech looking to make a comeback

6 years ago

Loxo chief Josh Bilenker steps in (temporarily) to head oncology R&D at Eli Lilly as Levi Garraway steps out

6 years ago

Athenex's oral chemotherapy formulation scores in pivotal study; Glycomine brings in $33M in Series B haul

6 years ago

Permira proposes to take Cambrex private in $2.4B deal, stirring up CDMO M&A

6 years ago

Teva to lose CFO, with turnaround still under construction

6 years ago

First page Previous page 924 925 926927928 929 930 Next page Last page